ASH 2022: Brukinsa Bests Imbruvica In Leukemia/Lymphoma PFS

Adds To ORR Benefits Shown Earlier

 
• By Dexter Jie Yan
Brukinsa final win
BeiGene finally hits finish line of comparative ALPINE trial in triumph • Source: Shutterstock

More from China

More from Focus On Asia